You are here: Home > Institute of Excellence (CPD) > CPD Events > PEACE 2021

PEACE 2021

Date: 31/10/2021 (AEDT)

Venue: Online Conference - ZOOM

Provider: PersonalEYES

Contact: Therese Consiglio, [E] theresec@personaleyes.com.au, [P] 0298762444

Learning Objectives

  • Identify when to refer to an Ophthalmologist
  • Recall a range of anti-VEGF treatments available in Australia
  • Recognise the potential side effects of anti-VEGF treatments
  • Recall risk factors associated with diabetes and pregnancy
  • Understand the recommended care plan for pregnant diabetic women.
  • Recognise the signs of some ocular conditions that require further investigation
  • Detect lesions on and around the eye that require further attention; and the required promptness of referral
  • Understand the various treatments to slow myopia progression in children
  • Recognise the signs of vitritis
  • Assess available treatments for various retinal conditions
  • Differentiate between common causes of retinal disease
  • Critique different treatment methods of reducing myopia progression
  • Compare different MIGs
  • Identify characteristics that indicate the use of MIGs
  • Recognise the evolving treatments available for dry eye
  • Identify the role of an Optometrist and Ophthalmologist in the treatment of dry eyes
  • Understand the treatments available for keratoconus
  • Evaluate the signs and symptoms of keratoconus
  • Understand the role of an Optometrist and Ophthalmologist in the treatment of glaucoma
  • Interpret visual field results and OCT scans to implement glaucoma treatment
  • Recall the signs and symptoms of a retinal detachment
  • Assess the various treatments for retinal detachment

Max CPD hours awarded: 11

Session Information

Name
Oculoplastics Part 2
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Paediatrics Update
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Interesting VR Cases
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Glaucoma and when not to do MIGs
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Dry Eye Treatments
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Keratoconus and Treatment 2021
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Glaucoma Pearls
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Advancements in Retinal Detachment
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Age Related Macula Degeneration Update
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Diabetic eye disease and Pregnancy
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Oculoplastics Update
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.